ABSTRACr A randomised, double-blind trial of atropine, atropine plus papaveretum, and atropine plus diazepam given intramuscularly as premedication for fibreoptic bronchoscopy in 60 patients showed no difference between the three regimens as assessed by bronchoscopist or patient. Bronchoscopists frequently attributed a sedative action to atropine alone and their assessment of tolerance and sedation was more optimistic than that of the patients. In a second study comparing intravenous diazepam (10 mg) with saline, after prior intramuscular atropine (0.6 mg), both the bronchoscopists and the patients noted a significant sedative effect of diazepam, and coughing was reduced by diazepam.
Premedication for fibreoptic bronchoscopy frequently consists of an intramuscular injection of an anticholinergic agent and an opiate or benzodiazepine 30-60 minutes before the procedure. The anticholinergic agent is necessary to prevent vasovagal phenomena,' reflex bronchoconstriction, and bradycardia. It also helps to decrease secretions in the pharynx and airways. Opiates are given both for their antitussive effect and for sedation and a combination of anticholinergic agent and opiate is often used as premedication before general anaesthesia.
Because of dissatisfaction with this regimen we compared the effects of atropine alone and in combination with either diazepam or papaveretum in 60 consecutive patients undergoing fibreoptic bronchoscopy. Since the study showed that none of these three combinations was satisfactory, we went on to assess the use of diazepam given intravenously at the time of the bronchoscopy.
Methods INTRAMUSCULAR ATROPINE, DIAZEPAM, AND

PAPAVARETUM
Sixty consecutive patients considered fit to have any of the three premedications were studied. All received 0-6 mg atropine, 20 received 10 mg diazepam, and 20 received 10, 15, or 20 mg of papaveretum, depending on weight and age (10 mg < 50 kg, 15 mg 50-70 kg or > 65 years, 20 mg > 70 kg and < 65 years). All drugs were given intramuscularly 20-40 minutes before patients came to the bronchoscopy suite. Patients and bronchoscopists were unaware of the premedication given, the order being randomised and chosen from a set of sealed envelopes. Topical anaesthesia was used for the oropharynx, larynx, and airways in the usual manner.2 The nasal route was used when possible, and was always attempted first. Bronchoscopy was performed with the patient supine. The same two experienced bronchoscopists performed the procedures and the assessments in both studies and in all cases an assistant was present.
Immediately after the bronchoscopy the bronchoscopist answered three questions on the sedative effect of the premedication, the extent of coughing, and the patient's tolerance. Two bronchoscopists were concerned in the assessment and each question had four possible answers (table 1). Between one and three hours after the bronchoscopy the patient completed questions on the sedative effect of the premedication and tolerance of the procedure (table  1) . Patients were also asked for their opinion on the worst part of the procedure. Assessment of premedication in the first few hours after bronchoscopy has been shown to reflect accurately the subsequent attitude of the patients.3
The Pearce found atropine premedication alone satisfactory for fibreoptic bronchoscopy5 but for gastroscopy the patients of Thompson and his colleagues preferred the additional sedation given by intravenous diazepam.6 Diazepam also has the advantage of an amnesic effect78 and has been found to be preferable to morphine premedication for gastroscopy.9 When used intravenously the dose can be adjusted to the individual patient's requirements. A recent study comparing oral temazepam with intramuscular papaveretum found no difference in coughing, relaxation, or consciousness but slightly less recall of the procedure after temazepam.'°Our results suggest that a placebo group might well have produced similar results. Opiate drugs might be expected to decrease coughing at bronchoscopy but this was not found in our study or in that of Dorward et al. ' 0 Differences between studies might reflect psychological differences between patients3 or differences in the psychological preparation of the patient by bronchoscopist or other staff."
Our initial study of three premedications was performed because of dissatisfaction with our routine premedication, which consisted of atropine and papaveretum. The results were analysed after the first 60 patients. They showed no significant difference between the premedications and disclosed much discomfort among the patients. There was a trend for patients to find the procedure less unpleasant with papaveretum (table 1). The tolerance of the procedure and the sedative effect were generally rated much worse by the patients than by the bronchoscopists. This indicates the importance of patients' opinions in such studies and shows that we often do not appreciate patients' responses to such procedures.
In the second study the bronchoscopists were less likely to attribute a sedative effect to atropine alone. This may have been because of the greater contrast with diazepam or because they adjusted their responses when aware of the results of the first study. They also appeared to be less optimistic in their assessment of patients' tolerance after atropine Rees, Hay, Webb alone in the second study. The second study showed that intravenous diazepam at the time of bronchoscopy was a useful addition to atropine alone, giving a sedative effect even with a fixed dose. The trend was for tolerance of the procedure to be improved by diazepam; coughing was reduced; and none of the patients receiving diazepam found the bronchoscopy too unpleasant to be considered again.
Anaesthesia of the vocal cords or passage of the bronchoscope through the larynx was the most unpleasant part of the procedure for 26 of the 60 patients. We have found anaesthetising the larynx by holding local anaesthetic in the pyriform fossae'2 to be equally unpleasant, but more controlled application of anaesthetic with a fine spray used locally may be more efficient.'3 The patients' opinions of the most unpleasant parts of the bronchoscopy emphasise the importance of careful anaesthesia of and passage through the upper airway.
We suggest that intravenous diazepam given during the bronchoscopy is a more satisfactory regimen than intramuscular papaveretum or diazepam beforehand. Care must, however, be taken with patients at risk of respiratory depression as diazepam cannot be reversed by naloxone in the same way as opiates. We have subsequently found the combination of prior intramuscular atropine and intravenous diazepam at the time of bronchoscopy to be very satisfactory for day-case bronchoscopies.
